NewsWorld Health Organization4 min read
WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

In short
The World Health Organization revised its list of essential medications to add new therapies for hepatitis C, drug-resistant tuberculosis, and multiple cancers. This update serves as a guide for national health agencies to prioritize cost-effective treatments and broaden equitable patient access globally.
Pro library
The three takeaways, why it matters for your work, and adding it to your page.
Studies, reports and articles picked for your craft every week, the full library, and a learning log on your page that shows your skills growing.
Black Friday price: $30 for 6 months, then $39 from 1 December. One payment, nothing renews.
Or read this week’s free picks →Read the original (free) at World Health Organization